1. Home
  2. EVC vs PEPG Comparison

EVC vs PEPG Comparison

Compare EVC & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

HOLD

Current Price

$3.15

Market Cap

288.4M

Sector

Industrials

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$5.45

Market Cap

317.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVC
PEPG
Founded
1996
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
288.4M
317.6M
IPO Year
2000
2022

Fundamental Metrics

Financial Performance
Metric
EVC
PEPG
Price
$3.15
$5.45
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$10.80
AVG Volume (30 Days)
234.7K
711.8K
Earning Date
03-05-2026
02-23-2026
Dividend Yield
6.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$420,178,000.00
N/A
Revenue This Year
$64.06
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.96
N/A
52 Week Low
$1.58
$0.88
52 Week High
$3.44
$7.80

Technical Indicators

Market Signals
Indicator
EVC
PEPG
Relative Strength Index (RSI) 52.40 47.69
Support Level $3.15 $5.19
Resistance Level $3.35 $6.20
Average True Range (ATR) 0.12 0.55
MACD -0.01 -0.09
Stochastic Oscillator 44.32 26.40

Price Performance

Historical Comparison
EVC
PEPG

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

Share on Social Networks: